Bicycle Therapeutics Announces Pricing of Initial Public Offering
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new class of therapeutics based on…
Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (Nasdaq: BCYC), a biotechnology company pioneering a new class of therapeutics based on…
HAWTHORNE, N.Y.–(BUSINESS WIRE)–Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and…
Enhanced senior management team to direct strategic, operational, financial, technological and business development initiatives LEHI, Utah–(BUSINESS WIRE)–Frelii Inc. (OTCQB: FRLI)…
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization…
Company Expands Its Opioid Blueprint in Order to Reduce Overdose Death in Underserved Communities PHILADELPHIA–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/AmeriHealthCaritas?src=hash" target="_blank"gt;#AmeriHealthCaritaslt;/agt;–AmeriHealth Caritas, a…
BRISBANE, Calif. & ST. LOUIS–(BUSINESS WIRE)–Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of best-in-class…
The meeting will feature nationally and regionally recognized speakers sharing the latest insights into advancements in managing patients with chronic…
DUBLIN–(BUSINESS WIRE)–The “Primary Sclerosing Cholangitis – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Primary Sclerosing…
DUBLIN–(BUSINESS WIRE)–The “Erectile Dysfunction – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Erectile Dysfunction –…
TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/biotechnology?src=hash" target="_blank"gt;#biotechnologylt;/agt;–Cyclica, a leading biotechnology company that commercialized Ligand Express® announced its novel, first-in-class drug design technology, Ligand…